186 EUR
9
5.08%
Last update Dec 15, 8:00 AM CET
Main market
Day range
186
186
Previous close
177
Open
186
Access this stock data via API
Subscribe
Ascendis Pharma A/S - ADR
186.00
9
5.08%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 213.6M 158.0M 101.0M 173.9M
Cost of revenue 22.4M 31.4M 17.5M 14.0M
Gross profit 191.3M 126.6M 83.4M 159.9M
Operating expense
Research & development 66.9M 72.0M 86.6M 79.3M
Selling general and admin 111.7M 105.7M 95.6M 78.8M
Other operating expenses
Operating income 11.0M -53.0M -100.8M 383K
Non operating interest income
Income 3.3M 55.1M 28.9M -14.9M
Expense 19.7M 33.0M 44.8M -5.0M
Other income expense -52.0M -4.1M 23.1M -39.1M
Pretax income -57.4M -35.0M -93.6M -37.4M
Tax provision 3.6M 3.8M 1.1M 1.1M
Net income -61.0M -38.9M -94.6M -38.5M
Basic EPS -1 -0.6 -1.6 -0.6
Diluted EPS -1 -0.8 -1.6 -0.6
Basic average shares 60.8M 60.5M 60.0M 59.8M
Diluted average shares 60.8M 63.9M 60.0M 59.8M
EBITDA 10.8M 2.3M -40.8M -37.9M
Net income from continuing op. -61.0M -38.9M -94.6M -38.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 35 minutes

14:24
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).